'Safety outcomes' diaporamas de présentation

HEAT PPCI

HEAT PPCI. H ow E ffective are A ntithrombotic T herapies in PPCI. Heparin versus Bivalirudin in PPCI. Dr Adeel Shahzad Dr Rod Stables (PI) Liverpool Heart and Chest Hospital Liverpool, UK. Background. Anti-thrombotic therapy in PPCI

970 views • 79 slides

Endpoints (also Outcomes, Major Response Variables)

Endpoints (also Outcomes, Major Response Variables). How do you determine whether the treatment is effective?. Randomization (?) Blinding (?) Well-defined target population (?) Appropriate control (?) Excellent follow-up (?) Adequate sample size (?) Appropriate interim monitoring (?)

685 views • 62 slides

G. Camporese (Padova)

692 views • 49 slides

Outline

Outline. General endpoint considerations Surrogate endpoints Composite endpoints Safety outcomes (adverse events). Outline. Some background Definitions Data collection considerations Reporting of safety outcomes Recommendations. Safety Outcomes: Some Viewpoints.

610 views • 48 slides

Learning Objectives

Learning Objectives. Metabolic Abnormalities Associated With T2D. CV Events With PPAR-gamma Agonists. Effect of Fibrates on CV Outcomes A Systematic Review and Meta-analysis. ACCORD Lipid Hazard Ratios for the Primary Outcome. Pioglitazone Meta-analysis Heart Failure & MI.

505 views • 37 slides

Pulmonary Embolism Thrombolysis Study an investigator-initiated, investigator-sponsored trial

Pulmonary Embolism Thrombolysis Study an investigator-initiated, investigator-sponsored trial. The PEITH Investigators. ClinicalTrials.gov # NCT00639743 EudraCT # 2006-005328-18. Rationale: risk-adjusted treatment of acute PE. Thrombolysis?. Primary

578 views • 27 slides

390 views • 22 slides

Safety Intelligence of Senior Managers and Safety Outcomes

Safety Intelligence of Senior Managers and Safety Outcomes. Laura Fruhen. Skills and traits of senior executive managers in relation to safety Abilities and Understanding regarding Information Safety risks to the organization Decision making (Kirwan, 2008). What is Safety Intelligence?.

552 views • 22 slides

276 views • 15 slides

+ 45

Adding up in the Waikato region. 15. + 45. + 372. = 432 in 2017. = 432 in 2018. = 432 in 2019. = 432 in 2020. = 2160 by 2021. WAIKATO REGIONAL ROAD SAFETY STRATEGY 2017 - 2021. VISION AND PURPOSE. Vision

147 views • 14 slides

The work of HSE in Scotland

The work of HSE in Scotland. Mike Cross Director of Scotland and Northern England Field Operations Directorate. Smith Commission Next Steps.

123 views • 12 slides

CDM Revised Regulatory Package Update

CDM Revised Regulatory Package Update. CDM Update. Background Policy Objectives Developing the package Consultation Next steps. Background. HSE Board Dec 2011: Revised Regulatory package Based on copy out of TMCSD Continue improvement in health and safety outcomes

228 views • 8 slides

Stroke or systemic embolic events in large NOAC trials, vs warfarin

Stroke or systemic embolic events in large NOAC trials, vs warfarin. Ruff et al ., The Lancet, 2013. S ecundary efficacy and safety outcomes in large NOAC trials, vs. warfarin. Ruff et al ., The Lancet, 2013. Major bleeding events in large NOAC trials, vs warfarin.

331 views • 3 slides